Allows for the provision of epinephrine in schools by methods other than injections.
Summary
SB 1504 updates Oregon law governing how epinephrine and related emergency medications may be administered in schools and in certain health-training contexts. The bill expands the definition of “premeasured dose” so epinephrine may be delivered not only by an autoinjector, but also by an intranasal device or any other method later approved by the State Board of Education or Oregon Health Authority by rule. It also revises school medication policies for students with asthma or severe allergies, including self-administration rules, backup medication storage, and classroom access to emergency epinephrine when medically necessary.
The bill also makes conforming changes to Oregon’s school liability protections and emergency-medication training statutes. It updates immunity provisions for school staff and districts when epinephrine is administered in good faith, and it changes training language so instruction on allergic reactions refers to premeasured epinephrine doses rather than only injections. Similar updates are made in the sections covering training for allergic responses, hypoglycemia, and adrenal insufficiency, allowing the state to recognize newer delivery methods and medication forms in school and public-health settings.
Impact
SB 1504 amends ORS 339.866, 339.867, 339.871, 433.800, 433.815, and 433.817 to modernize Oregon’s school and emergency-medication framework. Its main legal effect is to authorize epinephrine delivery by non-injection methods, including intranasal devices and other methods approved by rule, while preserving school district duties to adopt policies for student self-administration and backup medication access. It also extends and clarifies liability protections for school personnel and districts acting in good faith, and updates training requirements administered by health professionals and public-health entities. The bill takes effect January 1, 2027.
Sentiment
The bill appears to have broad bipartisan support and little visible opposition. It passed the Senate committee 5-0, the Senate floor 30-0, the House committee 8-0, and the House floor 53-0. The unanimous votes suggest general agreement that the bill is a practical update to school health and emergency-response rules, especially for students with severe allergies and asthma.
Contention
No committee transcript is available, and the voting record shows no recorded nays, so there is no clear evidence of major controversy. The most likely points of discussion would have been the shift from injection-only language to broader “premeasured dose” administration, the authority given to state agencies to approve additional delivery methods by rule, and the balance between student access to emergency medication and school oversight or liability concerns. The bill also preserves limits by allowing schools to revoke self-administration privileges if medication is misused and by excluding youth correction facilities from the school self-administration provisions.